Amgen Pharmacy Partnership in Osteoporosis INTervention (APPOINT) Program

In March 2019, Kos designed, developed, and implemented the Amgen Pharmacy Partnership in Osteoporosis INTervention (APPOINT) Program. Recognising the critical role that pharmacy plays in identifying and treating osteoporosis Amgen Australia has joined with PharmaPrograms to create the Program with the aim of supporting pharmacies to reduce osteoporotic fractures.